secwatch.observer — SEC 8-K summary
======================================

Issuer:     CareDx, Inc. (CDNA)
CIK:        0001217234
Form:       8-K
Filed at:   2022-11-03T23:59:59+00:00
Accession:  0001217234-22-000185
Event type: earnings
Sentiment:  negative
Materiality: 0.60
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

CareDx Q3: Revenue $79.4M (+5%), net loss widens to $16.9M; adj EBITDA loss $2.5M
--------------------------------------------------------------------------------

- Revenue $79.4M (+5% YoY); testing services $64.8M, product $7.2M, patient/digital $7.4M.
- Net loss $16.9M ($0.32 per share) vs $11.9M loss ($0.23) in Q3 2021.
- Non-GAAP net loss $3.4M vs non-GAAP income $4.0M; non-GAAP EPS -$0.06 vs +$0.07.
- Adjusted EBITDA loss $2.5M vs gain $4.7M; company targets positive adjusted EBITDA by H1 2023.
- Delivered 46,500 patient test results (+15% YoY); cash $291.3M, no debt.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1217234/000121723422000185/0001217234-22-000185-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1217234/000121723422000185/cdna-20221103.htm
  HTML page:      https://secwatch.observer/filing/0001217234-22-000185

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer